Stavros P. Neofotistos

Mr. Stavros P. Neofotistos

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2019 in ACS Omega
Verified
Journal Article
Open access
NTNIKOLAOS TZOURAS
NIKOLAOS TZOURAS
SNStavros P. Neofotistos
Stavros P. Neofotistos
Georgios C. VougioukalakisGeorgios C. Vougioukalakis
Georgios C. Vougioukalakis
Tetrasubstituted propargylamines comprise a unique class of highly useful compounds, which can be accessed through the multicomponent coupling between ketones, amines, and alkynes (KA2 coupling), an underexplored transformation. Herein, the development of a novel, highly efficient, and user-friendly catalytic system for the KA2 coupling, based on the environmentally benign, inexpensive, and readily available zinc acetate, is described. This system is employed in the multicomponent assembly of unprecedented, tetrasubstituted propargylamines derived from structurally diverse, challenging, and even biorelevant substrates. Notable features of this protocol include the demonstration of the enhancing effect that neat conditions can have on catalytic activity, as well as the expedient functionalization of hindered, prochiral cyclohexanones, linear ketones, and interesting molecular scaffolds such as norcamphor and nornicotine.

25 February 2023 in Catalysts
Verified
Journal Article
Open access
PDF file
SNStavros P. Neofotistos
Stavros P. Neofotistos
Andromachi TzaniAndromachi Tzani
Andromachi Tzani
Anastasia DetsiAnastasia Detsi
Anastasia Detsi
Ionic liquids are a family of liquids that are composed entirely of ions and usually have melting points lower than 100 °C. Extensive research, along with the ever-growing interest of the scientific community, allowed for the development of a multitude of ionic liquids with low melting points. Such compounds are considered neoteric materials as well as ideal, custom-made solvents for a variety of different chemical transformations. In this regard, the importance of phase transfer catalysis is evident in a diversity of substrates and reactions. The use of phase transfer catalysts allows the reaction to proceed, facilitating the transfer of otherwise insoluble reactants to the desired phase. Recent scientific advances led to the emergence of ionic liquids, which are excellent candidates as phase transfer catalysts. The inherent fine-tuning capability of these molecules, along with the potential of phase transfer catalytic reactions, epitomize the sustainable aspect of this field of research. Herein, a cohesive report of such applications will be presented, including the period from the last decade of the 20th century up to date.

24 May 2024 in Molecules
Verified
Journal Article
Open access
PDF file
PMPanagiou Mavroeidi
Panagiou Mavroeidi
LZLeandros Zorba
Leandros Zorba
NTNIKOLAOS TZOURAS
NIKOLAOS TZOURAS
SNStavros P. Neofotistos
Stavros P. Neofotistos
NGNikitas Georgiou
Nikitas Georgiou
Thomas MavromoustakosThomas Mavromoustakos
Thomas Mavromoustakos
A versatile family of quaternary propargylamines was synthesized employing the KA2 multicomponent reaction, through the single-step coupling of a number of amines, ketones, and terminal alkynes. Sustainable synthetic procedures using transition metal catalysts were employed in all cases. The inhibitory activity of these molecules was evaluated against human monoaminoxidase (hMAO)-A and hMAO-B enzymes and was found to be significant. The IC50 values for hMAO-B range from 152.1 to 164.7 nM while the IC50 values for hMAO-A range from 765.6 to 861.6 nM. Furthermore, these compounds comply with Lipinski’s rule of five and exhibit no predicted toxicity. To understand their binding properties with the two target enzymes, key interactions were studied using molecular docking, all-atom molecular dynamics (MD) simulations, and MM/GBSA binding free energy calculations. Overall, herein, the reported family of propargylamines exhibits promise as potential treatments for neurodegenerative disorders, such as Parkinson’s disease. Interestingly, this is the first time a propargylamine scaffold bearing an internal alkyne has been reported to show activity against monoaminoxidases.